Entinostat-Keytruda Clinical Trial in NSCLC Will Proceed to Next Stage
News
A clinical trial exploring entinostat in combination with Merck’s Keytruda (pembrolizumab) in non-small cell lung cancer (NSCLC) patients who progressed despite checkpoint-blocking treatment, met the required response threshold to advance ... Read more